Insights

Loading spinner
Gathering insights about NETRIS Pharma

NETRIS Pharma Tech Stack

NETRIS Pharma uses 8 technology products and services including WordPress, Google Font API, Vue.js, and more. Explore NETRIS Pharma's tech stack below.

  • WordPress
    Content Management System
  • Google Font API
    Font Scripts
  • Vue.js
    Javascript Frameworks
  • Select2
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Flying Pages
    Web Platform Extensions

Media & News

NETRIS Pharma's Email Address Formats

NETRIS Pharma uses at least 1 format(s):
NETRIS Pharma Email FormatsExamplePercentage
FirstLast@netrispharma.comJohnDoe@netrispharma.com
46%
First.Last@netrispharma.comJohn.Doe@netrispharma.com
4%
FirstMiddleLast@netrispharma.comJohnMichaelDoe@netrispharma.com
4%
FirstLast@netrispharma.comJohnDoe@netrispharma.com
46%

Frequently Asked Questions

Where is NETRIS Pharma's headquarters located?

Minus sign iconPlus sign icon
NETRIS Pharma's main headquarters is located at Lyon, Rhône-Alpes 69008 FR. The company has employees across 2 continents, including EuropeNorth America.

What is NETRIS Pharma's official website and social media links?

Minus sign iconPlus sign icon
NETRIS Pharma's official website is netrispharma.com and has social profiles on LinkedIn.

How much revenue does NETRIS Pharma generate?

Minus sign iconPlus sign icon
As of September 2024, NETRIS Pharma's annual revenue reached $3.8M.

What is NETRIS Pharma's NAICS code?

Minus sign iconPlus sign icon
NETRIS Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NETRIS Pharma have currently?

Minus sign iconPlus sign icon
As of September 2024, NETRIS Pharma has approximately 17 employees across 2 continents, including EuropeNorth America. Key team members include Chief Business Officer: F. S.Chief Financial Officer And Board Member: C. G.Chief Medical Officer: F. L. B.. Explore NETRIS Pharma's employee directory with LeadIQ.

What industry does NETRIS Pharma belong to?

Minus sign iconPlus sign icon
NETRIS Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does NETRIS Pharma use?

Minus sign iconPlus sign icon
NETRIS Pharma's tech stack includes WordPressGoogle Font APIVue.jsSelect2ModernizrHSTSX-XSS-ProtectionFlying Pages.

What is NETRIS Pharma's email format?

Minus sign iconPlus sign icon
NETRIS Pharma's email format typically follows the pattern of . Find more NETRIS Pharma email formats with LeadIQ.

How much funding has NETRIS Pharma raised to date?

Minus sign iconPlus sign icon
As of September 2024, NETRIS Pharma has raised $8.2M in funding. The last funding round occurred on Dec 19, 2023 for $8.2M.
NETRIS Pharma

NETRIS Pharma

Pharmaceutical ManufacturingRhône-Alpes, France11-50 Employees

Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group.
Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center.

Section iconCompany Overview

Headquarters
Lyon, Rhône-Alpes 69008 FR
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $8.2M

    NETRIS Pharma has raised a total of $8.2M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $8.2M.

  • $10M

    NETRIS Pharma's revenue is in the range of $10M

Section iconFunding & Financials

  • $8.2M

    NETRIS Pharma has raised a total of $8.2M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2023 in the amount of $8.2M.

  • $10M

    NETRIS Pharma's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.